Sevoflurane does not alter norepinephrine-induced intracellular Ca 2+ changes in the diabetic rat aorta

Canadian Journal of Anesthesia

Volumn 57, Issue 12, 2010, Pages 1095-1101

  Fujii, Keisuke ^a   Ogawa, Koji ^b   Tokinaga, Yasuyuki ^b   Iranami, Hiroshi ^a   Hatano, Yoshio ^b  

^a JAPANESE RED CROSS WAKAYAMA MEDICAL CENTER   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; ETHER DERIVATIVE; INHALATION ANESTHETIC AGENT; NORADRENALIN; SEVOFLURANE;

ANIMAL; AORTA; ARTICLE; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; LONG EVANS RAT; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT; PATHOPHYSIOLOGY; RAT; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ANESTHETICS, INHALATION; ANIMALS; AORTA; CALCIUM; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; MALE; METHYL ETHERS; MUSCLE, SMOOTH, VASCULAR; NOREPINEPHRINE; RATS; RATS, INBRED OLETF; RATS, LONG-EVANS; VASOCONSTRICTION;

EID: 79952308354     PISSN: 0832610X     EISSN: 14968975     Source Type: Journal    
DOI: 10.1007/s12630-010-9387-0     Document Type: Article

References (29)

1. Jermendy G. Clinical consequences of cardiovascular autonomic neuropathy in diabetic patients. Acta Diabetol 2003; 40(Suppl 2): S370-4. (Pubitemid 37549050)
2. Giorda CB, Avogaro A, Maggini M, et al. Incidence and risk factors for stroke in type 2 diabetic patients: the DAI study. Stroke. 2007; 38: 1154-60. (Pubitemid 351664268)
3. Koya D, King GL. Protein kinase C activation and the development of diabetic complications. Diabetes 1998; 47: 859-66. (Pubitemid 28255657)
4. Pierce GN, Maddaford TG, Russell JC. Cardiovascular dysfunction in insulin-dependent and non-insulin-dependent animal models of diabetes mellitus. Can J Physiol Pharmacol 1997; 75: 343-50. (Pubitemid 27304440)
5. Negoro T, Mizumoto K, Ogawa K, Hironaka Y, Kakutani T, Hatano Y. Effects of isoflurane and sevoflurane anesthesia on arteriovenous shunt flow in the lower limb of diabetic patients without autonomic neuropathy. Anesthesiology 2007; 107: 45-52. (Pubitemid 46987818)
6. Yu J, Ogawa K, Tokinaga Y, Iwahashi S, Hatano Y. The vascular relaxing effects of sevoflurane and isoflurane are more important in hypertensive than normotensive rats. Can J Anesth 2004; 51: 979-85. (Pubitemid 40104111)
7. Yu J, Tokinaga Y, Ogawa K, Iwahashi S, Hatano Y. Sevoflurane inhibits angiotensin II-induced, protein kinase C-mediated but not Ca2?-elicited contraction of rat aortic smooth muscle. Anesthesiology 2004; 100: 879-84. (Pubitemid 38392575)
8. Yu J, Ogawa K, Tokinaga Y, Hatano Y. Sevoflurane inhibits guanosine 5'-[gamma-thio] triphosphate-stimulated, Rho/Rhokinase- mediated contraction of isolated rat aortic smooth muscle. Anesthesiology 2003; 99: 646-51. (Pubitemid 37051980)
9. Yu J, Mizumoto K, Tokinaga Y, Ogawa K, Hatano Y. The inhibitory effects of sevoflurane on angiotensin II-induced, p44/42 mitogen-activated protein kinase-mediated contraction of rat aortic smooth muscle. Anesth Analg 2005; 101: 315-21. (Pubitemid 41045203)
10. Ramsey PH, Ramsey PP. Power and type I errors for pairwise comparisons of means in the unequal variances case. Br J Math Stat Psychol 2009; 62(Pt 2): 263-81.
11. Duncan ER, Walker SJ, Ezzat VA, et al. Accelerated endothelial dysfunction in mild prediabetic insulin resistance: the early role of reactive oxygen species. Am J Physiol Endocrinol Metab 2007; 293: E1311-9. (Pubitemid 350106599)
12. Cameron NE, Cotter MA. Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: role of polyol pathway. Diabetologia 1992; 35: 1011-9.
13. Taylor PD, Oon BB, Thomas CR, Poston L. Prevention by insulin treatment of endothelial dysfunction but not enhanced noradrenaline- induced contractility in mesenteric resistance arteries Fig. 4 The effects of sevoflurane on norepinephrine (NE 10-6M)- induced elevation of intracellular Ca2 concentration ([Ca2]i) of aortic smooth muscle in Long Evans Tokushima Otsuka (LETO) rats and Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Sevoflurane did not affect the increase in [Ca2]i (n = 5) in response to NE in OLETF rats, but it inhibited the response in LETO rats. Changes in [Ca2]i are expressed relative to those induced by KCl 30 mM. Twoway analysis of variance revealed a significant interaction between rat type and sevoflurane concentration (P = 0.002) 1100 K. Fujii et al. from streptozotocin-induced diabetic rats. Br J Pharmacol 1994; 111: 35-41.
14. Fulton DJ, Hodgson WC, Sikorski BW, King RG. Attenuated responses to endothelin-1, KCl and CaCl2, but not noradrenaline, of aortae from rats with streptozotocin-induced diabetes mellitus. Br J Pharmacol 1991; 104: 928-32.
15. Lenzen S. The mechanisms of alloxan- and streptozotocininduced diabetes. Diabetologia 2008; 51: 216-26.
16. Kawano K, Hirashima T, Mori S, Natori T. OLETF (Otsuka Long-Evans Tokushima Fatty) rat: a new NIDDM rat strain. Diabetes Res Clin Pract 1994; 24: S317-20.
17. Russell JC. Reduction and prevention of the cardiovascular sequelae of the insulin resistance syndrome. Curr Drug Targets Cardiovasc Haematol Disord 2001; 1: 107-20.
18. Nobe K, Sakai Y, Maruyama Y, Momose K. Hyper-reactivity of diacylglycerol kinase is involved in the dysfunction of aortic smooth muscle contractility in streptozotocin-induced diabetic rats. Br J Pharmacol 2002; 136: 441-51. (Pubitemid 34620525)
19. Brondum E, Kold-Petersen H, Nilsson H, Flyvbjerg A, Aalkjaer C. Increased contractility to noradrenaline and normal endothelial function in mesenteric small arteries from the Goto-Kakizaki rat model of type 2 diabetes. J Physiol Sci 2008; 58: 333-9.
20. Winters B, Mo Z, Brooks-Asplund E, et al. Reduction of obesity, as induced by leptin, reverses endothelial dysfunction in obese (Lep(ob)) mice. J Appl Physiol 2000; 89: 2382-90.
21. Lesniewski LA, Donato AJ, Behnke BJ, et al. Decreased NO signaling leads to enhanced vasoconstrictor responsiveness in skeletal muscle arterioles of the ZDF rat prior to overt diabetes and hypertension. Am J Physiol Heart Circ Physiol 2008; 294: H1840-50. (Pubitemid 351490614)
22. Kobayashi T, Matsumoto T, Ooishi K, Kamata K. Differential expression of alpha2D-adrenoceptor and eNOS in aortas from early and later stages of diabetes in Goto-Kakizaki rats. Am J Physiol Heart Circ Physiol 2004; 287: H135-43. (Pubitemid 38802345)
23. Akata T, Kanna T, Yoshino J, Takahashi S. Mechanisms of direct inhibitory action of isoflurane on vascular smooth muscle of mesenteric resistance arteries. Anesthesiology 2003; 99: 666-77. (Pubitemid 37051983)
24. Akata T, Nakashima M, Izumi K. Comparison of volatile anesthetic actions on intracellular calcium stores of vascular smooth muscle: investigation in isolated systemic resistance arteries. Anesthesiology 2001; 94: 840-50. (Pubitemid 32429755)
25. Yoo HJ, Kozaki K, Akishita M, et al. Augmented Ca2 ? influx is involved in the mechanism of enhanced proliferation of cultured vascular smooth muscle cells from spontaneously diabetic Goto-Kakizaki rats. Atherosclerosis 1997; 131: 167-75. (Pubitemid 27232438)
26. Evans JF, Lee JH, Ragolia L. Ang-II-induced Ca(2 ?) influx is mediated by the 1/4/5 subgroup of the transient receptor potential proteins in cultured aortic smooth muscle cells from diabetic Goto-Kakizaki rats. Mol Cell Endocrinol 2009; 302: 49-57.
27. Akata T. Cellular and molecular mechanisms regulating vascular tone. Part 2: regulatory mechanisms modulating Ca2 ? mobilization and/or myofilament Ca2 ? sensitivity in vascular smooth muscle cells. J Anesth 2007; 21: 232-42. (Pubitemid 46692016)
28. Qi F, Ogawa K, Tokinaga Y, Uematsu N, Minonishi T, Hatano Y. Volatile anesthetics inhibit angiotensin II-induced vascular contraction by modulating myosin light chain phosphatase inhibiting protein, CPI-17 and regulatory subunit, MYPT1 phosphorylation. Anesth Analg 2009; 109: 412-7.
29. Mueed I, Zhang L, MacLeod KM. Role of the PKC/CPI-17 pathway in enhanced contractile responses of mesenteric arteries from diabetic rats to alpha-adrenoceptor stimulation. Br J Pharmacol 2005; 146: 972-82. (Pubitemid 41722170)